317 related articles for article (PubMed ID: 9452489)
1. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate.
Haltiwanger RS; Grove K; Philipsberg GA
J Biol Chem; 1998 Feb; 273(6):3611-7. PubMed ID: 9452489
[TBL] [Abstract][Full Text] [Related]
2. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
[TBL] [Abstract][Full Text] [Related]
3. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K; Wells L; Lane MD; Hart GW
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.
Park SY; Ryu J; Lee W
Exp Mol Med; 2005 Jun; 37(3):220-9. PubMed ID: 16000877
[TBL] [Abstract][Full Text] [Related]
5. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
Johnson B; Opimba M; Bernier J
Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of O-GlcNAcase by PUGNAc is dependent upon the oxime stereochemistry.
Perreira M; Kim EJ; Thomas CJ; Hanover JA
Bioorg Med Chem; 2006 Feb; 14(3):837-46. PubMed ID: 16214344
[TBL] [Abstract][Full Text] [Related]
7. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells.
Gao Y; Parker GJ; Hart GW
Arch Biochem Biophys; 2000 Nov; 383(2):296-302. PubMed ID: 11185566
[TBL] [Abstract][Full Text] [Related]
8. Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.
Arias EB; Kim J; Cartee GD
Diabetes; 2004 Apr; 53(4):921-30. PubMed ID: 15047606
[TBL] [Abstract][Full Text] [Related]
9. Relationship between protein O-linked glycosylation and insulin-stimulated glucose transport in rat skeletal muscle following calorie restriction or exposure to O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate.
Arias EB; Cartee GD
Acta Physiol Scand; 2005 Mar; 183(3):281-9. PubMed ID: 15743388
[TBL] [Abstract][Full Text] [Related]
10. PUGNAc treatment leads to an unusual accumulation of free oligosaccharides in CHO cells.
Mehdy A; Morelle W; Rosnoblet C; Legrand D; Lefebvre T; Duvet S; Foulquier F
J Biochem; 2012 Apr; 151(4):439-46. PubMed ID: 22337894
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic O-GlcNAc accumulation is not involved in beta-cell death in HIT-T15 or Min6.
Okuyama R; Yachi M
Biochem Biophys Res Commun; 2001 Sep; 287(2):366-71. PubMed ID: 11554736
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis.
Rao FV; Dorfmueller HC; Villa F; Allwood M; Eggleston IM; van Aalten DM
EMBO J; 2006 Apr; 25(7):1569-78. PubMed ID: 16541109
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc modification of proteins affects volume regulation in Jurkat cells.
Nagy T; Balasa A; Frank D; Rab A; Rideg O; Kotek G; Magyarlaki T; Bogner P; Kovács GL; Miseta A
Eur Biophys J; 2010 Jul; 39(8):1207-17. PubMed ID: 20043149
[TBL] [Abstract][Full Text] [Related]
14. Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1.
Gandy JC; Rountree AE; Bijur GN
FEBS Lett; 2006 May; 580(13):3051-8. PubMed ID: 16684529
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed proteins by treatment with PUGNAc in 3T3-L1 adipocytes through analysis of ATP-binding proteome.
Lee JE; Park JH; Moon PG; Baek MC
Proteomics; 2013 Oct; 13(20):2998-3012. PubMed ID: 23946262
[TBL] [Abstract][Full Text] [Related]
16. The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels.
Zou L; Yang S; Hu S; Chaudry IH; Marchase RB; Chatham JC
Shock; 2007 Apr; 27(4):402-8. PubMed ID: 17414423
[TBL] [Abstract][Full Text] [Related]
17. Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise.
Whitworth GE; Macauley MS; Stubbs KA; Dennis RJ; Taylor EJ; Davies GJ; Greig IR; Vocadlo DJ
J Am Chem Soc; 2007 Jan; 129(3):635-44. PubMed ID: 17227027
[TBL] [Abstract][Full Text] [Related]
18. Selective decrease of membrane-associated PKC-alpha and PKC-epsilon in response to elevated intracellular O-GlcNAc levels in transformed human glial cells.
Matthews JA; Acevedo-Duncan M; Potter RL
Biochim Biophys Acta; 2005 Apr; 1743(3):305-15. PubMed ID: 15843043
[TBL] [Abstract][Full Text] [Related]
19. Dissecting PUGNAc-mediated inhibition of the pro-survival action of insulin.
Teo CF; El-Karim EG; Wells L
Glycobiology; 2016 Nov; 26(11):1198-1208. PubMed ID: 27072814
[TBL] [Abstract][Full Text] [Related]
20. Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats.
Akimoto Y; Kawakami H; Yamamoto K; Munetomo E; Hida T; Hirano H
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3802-9. PubMed ID: 12939295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
